Risk of cancer after initiation of targeted therapies in patients with rheumatoid arthritis and a prior cancer: systematic review with meta‐analysis-Reference-Cited by-同舟云学术

Risk of cancer after initiation of targeted therapies in patients with rheumatoid arthritis and a prior cancer: systematic review with meta‐analysis

Published:2021-09-21 Issue: Volume: Page:
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Wetzman Amélie¹^ORCID,Lukas Cédric¹²,Gaujoux‐Viala Cécile²³,Mamtani Ronac⁴⁵,Barnetche Thomas⁶,Combe Bernard¹,Morel Jacques¹^ORCID,Szafors Paulina¹^ORCID

Affiliation:

1. Department of Rheumatology Montpellier University Hospital University of Montpellier‐Nimes Montpellier France

2. UMR 1302 Institute Desbrest of Epidemiology and Public Health INSERM Univ Montpellier Montpellier France

3. Department of Rheumatology Nîmes University Hospital Nîmes France

4. Center for Clinical Epidemiology and Biostatistics University of Pennsylvania

5. Abramson Cancer Center University of Pennsylvania

6. Department of Rheumatology FHU ACRONIM CHU Pellegrin Bordeaux France

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.24784

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in the use of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and recently diagnosed colorectal, lung, or prostate cancer;Clinical Rheumatology;2024-09-04

2. Survival in patients with rheumatoid arthritis and early breast cancer treated with tumor necrosis factor inhibitors;Breast Cancer;2024-08-08

3. A state-of-the-art systematic review of cancer in hidradenitis suppurativa;Annals of Medicine;2024-07-24

4. A Systematic Overview of Contraindications and Special Warnings for Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs: Establishing a Framework to Create a “Safety Checklist”;Drug Safety;2024-07-16

5. Rational approach to the prescription of anti-rheumatic drugs in rheumatoid arthritis: a product leaflet-based strategy in Italy;Frontiers in Immunology;2024-06-24